Company
SBC showcases EXOBELLA™, a groundbreaking innovation.
Schweitzer Biotech Company
Over 40 years of cell culture expertise benefiting human & animal health.
Cell therapy – engineered Mensenchymal Stem Cell & immune cell drug therapies
TaiwanBio (subsidiary entity) advances Phase II Clinical trial products & collaboration with Mayo Clinics
Vaccine – proficiency in Cell-based subunit vaccine technology
Recognized by WHO’s COVID-19 Technology Access Pool (C-TAP) & receied Taiwan EUA approval
Diagnostic – develop Saliva rapid antigen & veterinary diagnostic kits
Fast response to COVID-19 detection in Taiwan & African Swine Fever in the Phillipines & Avian Influenza
Dietary Supplement – Patent Probiotics leading the health industry
Costco SuperStore’s Top 1 Selling Probiotic food supplement – Weider
Our
Story
Schweitzer Biotech Company Ltd. (SBC) is a dynamic and innovative company dedicated to developing new solutions that contribute to the wellbeing of humans, animals, and the environment.
With more than 40 years of experience in the development, production, and registration of vaccines for animal diseases, SBC takes pride in providing its global customers with breakthrough technologies to accomplish their goals and strengthen their market position. SBC has collaborated with the world’s top 10 animal health companies and built an excellent reputation in animal disease prevention and control.
In recent years, SBC has diversified its business activities to animal disease diagnostics, human vaccines, dietary supplements, and environmentally friendly technologies.
A Taiwan-based world leader in bio-technology